30.10.2015 11:45:54
|
Mallinckrodt Announces Approval Of INOmax In Australia And Japan
(RTTNews) - Mallinckrodt plc (MNK) announced that INOmax (nitric oxide) for inhalation has received regulatory approval in Australia and Japan for pulmonary hypertension in conjunction with heart surgery.
INOmax is a vasodilator that opens (dilates) blood vessels, improving oxygen uptake and blood flow. It is used in conjunction with ventilator support and other appropriate agents. INOmax decreases pulmonary arterial pressure and improves oxygenation.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Mallinckrodt PLCmehr Nachrichten
Keine Nachrichten verfügbar. |